HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virginia M Sanders Selected Research

Flavin Mononucleotide (FMN)

12/2015CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.
7/2014Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.
2/2010Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy.
1/2010Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.
5/2008Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
10/2003CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Virginia M Sanders Research Topics

Disease

7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 09/2009
3Facial Nerve Injuries
12/2009 - 10/2008
2Disease Progression
07/2014 - 12/2011
2Spinal Cord Injuries (Spinal Cord Injury)
09/2009 - 11/2006
2Peripheral Nerve Injuries
05/2008 - 10/2003
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2018
1Macular Degeneration (Age-Related Maculopathy)
05/2010
1Facial Paralysis (Facial Palsy)
01/2010
1Atrophy
09/2009
1Contusions
09/2007
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2006
1Asthma (Bronchial Asthma)
09/2006
1Cutaneous Leishmaniasis
02/2005
1Infections
02/2005

Drug/Important Bio-Agent (IBA)

6Flavin Mononucleotide (FMN)IBA
12/2015 - 10/2003
2Messenger RNA (mRNA)IBA
12/2009 - 09/2009
2ChemokinesIBA
09/2009 - 02/2005
2AntigensIBA
09/2007 - 11/2006
1Death Domain ReceptorsIBA
07/2014
1Interleukin-10 (Interleukin 10)IBA
07/2011
1Bevacizumab (Avastin)FDA Link
05/2010
1Chemokine ReceptorsIBA
12/2009
1Superoxide Dismutase-1IBA
09/2009
1Caspase 3 (Caspase-3)IBA
09/2009
1Hormones (Hormone)IBA
09/2009
1CytokinesIBA
10/2008
1Interferon-gamma (Interferon, gamma)IBA
10/2008
1Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2007
1CorticosteroneIBA
09/2007
1Proteins (Proteins, Gene)FDA Link
09/2007
1Antinuclear AntibodiesIBA
11/2006
1AutoantibodiesIBA
11/2006
1Immunoglobulin E (IgE)IBA
09/2006
1Immunoglobulin G (IgG)IBA
02/2005
1Interleukin-12 (IL 12)IBA
02/2005
1CXCR3 ReceptorsIBA
02/2005

Therapy/Procedure

5Axotomy
01/2018 - 09/2009